Natixis Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Natixis Advisors's RGEN Position: Q1 2026 in Review
Natixis Advisors reduced its Repligen (RGEN) stake by 3.5% in Q1 2026, selling an estimated $145K and leaving 28,233 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #950.
Natixis Advisors first reported a position in RGEN in Q3 2021 and has held it in 19 quarters since. The position peaked at $41.6M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Natixis Advisors held 28,233 shares of Repligen worth $3.33M as of Q1 2026.
- Natixis Advisors sold 1,038 Repligen shares in Q1 2026, an estimated $145K.
- Repligen made up ﹤0.01% of Natixis Advisors's portfolio in Q1 2026, its #950 holding.
- Natixis Advisors first reported a position in Repligen in Q3 2021 and has held it in 19 quarters since.
- Natixis Advisors's Repligen position peaked at $41.6M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.